Drug Shortage Report for 5% DEXTROSE INJECTION USP
Report ID | 34510 |
Drug Identification Number | 01924281 |
Brand name | 5% DEXTROSE INJECTION USP |
Common or Proper name | Dextrose |
Company Name | B. BRAUN MEDICAL INC |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 150mL |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-12-22 |
Actual start date | 2017-12-22 |
Estimated end date | Unknown |
Actual end date | 2019-01-01 |
Shortage status | Resolved |
Updated date | 2019-11-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 824 TWELFTH AVENUE BETHLEHEM, PENNSYLVANIA UNITED STATES 18018 |
Company contact information | Cindy Katsempris; cindy.katsempris@bbraunusa.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-01-02 | English | Compare |
v2 | 2018-01-02 | French | Compare |
v3 | 2019-11-06 | English | Compare |
v4 | 2019-11-06 | French | Compare |
Showing 1 to 4 of 4